Close Menu

NEW YORK – Molecular diagnostics firm Agendia has settled with the US government for $8.25 million over allegations of Medicare fraud, the US Department of Justice, Western District of Kentucky announced on Wednesday.

The DOJ alleged that the company, which has offices in the Netherlands and Irvine, California, conspired with hospitals to "artificially delay" ordering the firm's MammaPrint genetic test for breast cancer in order to circumvent Medicare's 14-day rule, which determines who can bill Medicare for certain lab services.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.